glp-1 drug makers Food warn GLP-1s will have 'lasting influence' on sector India plans incentives for diabetes,

And eventually, it may be evidence payers, clinicians, employers, and patients all start asking for.

GLP-1 medications such as Ozempic may help lower the risk of certain cancers.

Learn about GLP-1 Agonists: Obesity & Alzheimers Breakthrough in research and their implications for cognitive health and obesity management.

Roche reported positive Phase II topline data showing that its once-weekly dual glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptor agonist CT-388 achieved substantial, sustained, and dose-dependent weight loss through 48 weeks

Preclinical studies have confirmed that GIPRGLP1R coagonists improve several hallmarks of metabolic syndrome, such as obesity, hyperglycemia, and dyslipidemia

Your satisfaction is our top priority, and we're here to ensure you have a positive experience with our products